The role of intravenous immunoglobulin in the treatment of cerebral vasospasm induced by subarachnoid haemorrhage: An experimental study

References

• Kolias AG, Sen J, Belli A. Pathogenesis of cerebral vasospasm following aneurismal subarachnoid hemorrhage: Putative mechanisms and novel approaches. Neuroscience Research 2009; 87: 1–11
   Google Scholar
• Rothoerl RD, Ringel F. Molecular mechanisms of cerebral vasospasm following aneurysmal SAH. Neurological Research 2007; 29: 636–642
   PubMed Web of Science ®Google Scholar
• Chaichana KL, Pradilla G, Huang J, Tamargo RJ. Role of inflammation (leukocyteendothelial cell interactions) in vasospasm after subarachnoid hemorrhage. World Neurosurgery 2010; 73: 22–41
   PubMed Web of Science ®Google Scholar
• Dumont AS, Dumont RJ, Chow MM, et al. Cerebral vasospasm after subarachnoid hemorrhage: Putative role of inflammation. Neurosurgery 2003; 53: 123–133
   PubMed Web of Science ®Google Scholar
• Clynes R. Immune complexes as therapy for autoimmunity. Journal of Clinical Investigation 2005; 115: 25–27
   PubMed Web of Science ®Google Scholar
• Keyrouz SG, Diringer MN. Prevention and therapy of vasospasm in subarachnoid hemorrhage. Clinical review Critical Care 2007; 11: 220
   PubMed Web of Science ®Google Scholar
• Bowman G, Bonneau RH, Chinchilli VM, Tracey KJ, Cockroft KM. A novel inhibitor of inflammatory cytokine production (CNI-1493) reduces rodent post-hemorrhagic vasospasm. Neurocritical Care 2006; 5: 222–229
   PubMedGoogle Scholar
• Arumugam TV, Woodruff TM, Lathia JD, Selvaraj PK, Mattson MP, Taylor SM. Neuroprotection in stroke by complement inhibition and immunoglobulin therapy. Neuroscience. 2009; 6(158)1074–1089
   Google Scholar
• Lutz HU, Späth PJ. Anti-inflammatory effect of intravenous immunoglobulin mediated through modulation of complement activation. Clinical Reviews in Allergy and Immunology 2005; 29: 207–212
   PubMedGoogle Scholar
• Güney O, Erdi F, Esen H, Kiyici A, Kocaogullar Y. N-acetylcysteine prevents vasospasm after subarachnoid hemorrhage. World Neurosurgery 2010; 73: 42–49
   PubMedGoogle Scholar
• Kocaogullar Y, Ilik K, Esen H, Koc O, Guney O. Preventive effects of intraperitoneal selenium on cerebral vasospasm: In experimental subarachnoid hemorrhage. Journal of Neurosurgical Anesthesiology 2009; 23: 53–58
   Google Scholar
• Arumugam TV, Tang SC, Lathia JD, Cheng A, Mughal MR, Chigurupati S, Magnus T, Chan SL, Jo DG, Ouyang X, et al. Intravenous immunoglobulin (IVIG) protects the brain against experimental stroke by preventing complement-mediated neuronal cell death. Proceedings of the National Academy of Science USA 2007; 28(104)14104–141049
   Google Scholar
• Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid rection. Analytical Biochemistry 1979; 95: 351–358
   PubMed Web of Science ®Google Scholar
• Bhardwaj A. SAH-induced cerebral vasospasm: Unraveling molecular mechanisms of a complex disease. Stroke 2003; 34: 427–433
   PubMedGoogle Scholar
• Mocco J, Mack WJ, Ducruet AF, Sosunov SA, Sughrue ME, Hassid BG, Nair MN, Laufer I, Komotar RJ, Claire M, et al. Complement component C3 mediates inflammatory injury following focal cerebral ischemia. Circulation Research 2006; 21(99)209–217
   Google Scholar
• Gallia GL, Tamargo RJ. Leukocyte-endothelial cell interactions in chronic vasospasm after subarachnoid hemorrhage. Neurological Research 2006; 28: 750–758
   PubMed Web of Science ®Google Scholar
• Zhang JH. Editorial: Experimental subarachnoid hemorrhage second issue: Cerebral vasospasm. Neurological Research 2006; 28: 687–689
   PubMed Web of Science ®Google Scholar
• Cahill J, Calvert JW, Zhang JH. Mechanisms of early brain injury after subarachnoid hemorrhage. Journal of Cerebral Blood Flow and Metabolism 2006; 26: 1341–1353
   PubMed Web of Science ®Google Scholar
• Komotar RJ, Zacharia BE, Valhora R, Mocco J, Connolly ES, Jr. Advances in vasospasm treatment and prevention. Journal of Neurological Sciences 2007; 15(261)134–142
   Google Scholar
• Naval NS, Stevens RD, Mirski MA, Bhardwaj A. Controversies in the management of aneurysmal subarachnoid hemorrhage. Critical Care in Medicine 2006; 34: 511–524
   PubMed Web of Science ®Google Scholar
• Rus H, Cudrici C, Niculescu F. C5b-9 complement complex in autoimmune demyelination and multiple sclerosis: Dual role in neuroinflammation and neuroprotection. Annals of Medicine 2005; 37: 97–104
   PubMed Web of Science ®Google Scholar
• Stangel M, Compston A, Scolding NJ. Oligodendroglia are protected from antibodymediated complement injury by normal immunoglobulins (“IVIg”). Journal of Neuroimmunology 2000; 103: 195–201
   PubMed Web of Science ®Google Scholar
• Ballow M. Mechanisms of action of intravenous immune serum globulin in autoimmune and inflammatory diseases. Journal of Allergy and Clinical Immunology 1997; 100: 151–157
   PubMed Web of Science ®Google Scholar
• Latremouille C, Genevaz D, Hu MC, Schussler O, Goussef N, Mandet C, Bruneval P, Haeffner-Cavaillon N, Carpentier A, Glotz D. Normal human immunoglobulins for intravenous use (IVIg) delayhyperacute xenograft rejection through F(ab′)2-mediated anticomplement activity. Clinical and Experimental Immunology 1997; 110: 122–126
   PubMedGoogle Scholar
• Park-Min KH, Serbina NV, Yang W, Ma X, Krystal G, Neel BG, Nutt SL, Hu X, Ivashkiv LB. FcgammaRIII-dependent inhibition of interferon-gamma responses mediates suppressive effects of intravenous immune globulin. Immunity 2007; 26: 67–78
   PubMedGoogle Scholar
• Boros P, Gondolesi G, Bromberg JS. High dose intravenous immunoglobulin treatment: Mechanisms of action. Liver Transplant 2005; 11: 1469–1480
   PubMedGoogle Scholar
• Arumugam TV, Selvaraj PK, Woodruff TM, Mattson MP. Targeting ischemic brain injury with intravenous immunoglobulin. Expert Opinion on Therapeutic Targets 2008; 12: 19–29
   PubMed Web of Science ®Google Scholar
• Aukrust P, Yndestad A, Ueland T, Damås JK, Frøland SS, Gullestad L. The role of intravenous immunoglobulin in the treatment of chronic heart failure. International Journal of Cardiology 2006; 10(112)40–45
   Google Scholar
• Arredondo J, Chernyavsky AI, Karaouni A, Grando SA. Novel mechanisms of target cell death and survival and of therapeutic action of IVIg in Pemphigus. American Journal of Pathology 2005; 167: 1531–1544
   PubMed Web of Science ®Google Scholar
• Orbach H, Katz U, Sherer Y, Shoenfeld Y. Intravenous immunoglobulin: Adverse effects and safe administration. Clinical Reviews in Allergy and Immunology 2005; 29: 173–184
   PubMed Web of Science ®Google Scholar